Stock IMPL IPI LEGACY LIQUIDATION CO
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights IPI Legacy Liquidation Co

Equities

IMPL

US45258K1097

Delayed OTC Markets
Other stock markets
 02:08:57 2024-04-05 pm EDT 		5-day change 1st Jan Change
0.015 USD 0.00% Intraday chart for IPI Legacy Liquidation Co 0.00% -87.85%
Apr. 12 North American Morning Briefing : Big Banks Kick -2- DJ
Apr. 05 North American Morning Briefing : Investors on -2- DJ

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : Stocks Struggle After New Records
DJ
An undisclosed buyer completed the acquisition of substantially all assets of Impel Pharmaceuticals Inc. for $17.5 million.
CI
Impel Pharmaceuticals Files for Chapter 11 to Facilitate Sale
CI
An undisclosed buyer entered into an agreement to acquire substantially all assets of Impel Pharmaceuticals Inc. for $17.5 million.
CI
Impel Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Impel Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Impel Pharmaceuticals Announces to Present New Real-World Data for Trudhesa® at 65th Annual Scientific Meeting of American Headache Society
CI
Impel Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa®? Nasal Spray Is Safe to Use When Co-Administered with Commonly Prescribed Migraine Medications
CI
IMPEL PHARMACEUTICALS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
AQ
Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
GL
Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
GL
Impel Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Corporate Update
GL
Impel Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Corporate Update
AQ
Impel Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Impel PHARMACEUTICALS : Announces SECOND Quarter 2022 Financial Results and Provides CORPORATE Update - Form 8-K
PU
Impel Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update
GL
Impel Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update
GL
Impel Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMPL Stock
  4. News IPI Legacy Liquidation Co
  5. Highlights